These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 26067908)
1. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium. Rangarajan R; Kraybill B; Ogundele A; Ketelson HA J Ocul Pharmacol Ther; 2015 Oct; 31(8):491-7. PubMed ID: 26067908 [TBL] [Abstract][Full Text] [Related]
2. Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent. Ubels JL; Clousing DP; Van Haitsma TA; Hong BS; Stauffer P; Asgharian B; Meadows D Curr Eye Res; 2004 Jun; 28(6):437-44. PubMed ID: 15512952 [TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation of a New Hydroxypropyl-Guar Phospholipid Nanoemulsion-Based Artificial Tear Formulation in Models of Corneal Epithelium. Rangarajan R; Ketelson H J Ocul Pharmacol Ther; 2019; 35(1):32-37. PubMed ID: 30489200 [TBL] [Abstract][Full Text] [Related]
4. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. Rolando M; Autori S; Badino F; Barabino S J Ocul Pharmacol Ther; 2009 Jun; 25(3):271-8. PubMed ID: 19366323 [TBL] [Abstract][Full Text] [Related]
5. Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies. Srinivasan S; Garofalo R; Williams R Clin Ophthalmol; 2023; 17():3883-3898. PubMed ID: 38105908 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a hydroxypropyl guar/polyethylene glycol/propylene glycol-based lubricant eye-drop in patients with dry eye. Labetoulle M; Messmer EM; Pisella PJ; Ogundele A; Baudouin C Br J Ophthalmol; 2017 Apr; 101(4):487-492. PubMed ID: 27422973 [TBL] [Abstract][Full Text] [Related]
7. Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome. Tseng CL; Hung YJ; Chen ZY; Fang HW; Chen KH PLoS One; 2016; 11(6):e0157982. PubMed ID: 27336157 [TBL] [Abstract][Full Text] [Related]
8. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye. Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model. She Y; Li J; Xiao B; Lu H; Liu H; Simmons PA; Vehige JG; Chen W J Ocul Pharmacol Ther; 2015 Nov; 31(9):525-30. PubMed ID: 26322539 [TBL] [Abstract][Full Text] [Related]
10. [Potential for use of hydroxypropyl guar in tear substitute therapy]. Brzhesky VV; Golubev SY Vestn Oftalmol; 2017; 133(1):88-96. PubMed ID: 28291206 [TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease. Lee D; Lu Q; Sommerfeld SD; Chan A; Menon NG; Schmidt TA; Elisseeff JH; Singh A Acta Biomater; 2017 Jun; 55():163-171. PubMed ID: 28363785 [TBL] [Abstract][Full Text] [Related]
12. Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model. Carlson E; Kao WWY; Ogundele A J Ocul Pharmacol Ther; 2018 May; 34(4):360-364. PubMed ID: 29394128 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study. Labetoulle M; Schmickler S; Galarreta D; Böhringer D; Ogundele A; Guillon M; Baudouin C Clin Ophthalmol; 2018; 12():2499-2508. PubMed ID: 30584269 [TBL] [Abstract][Full Text] [Related]
14. Corneal protection with high-molecular-weight hyaluronan against in vitro and in vivo sodium lauryl sulfate-induced toxic effects. Pauloin T; Dutot M; Liang H; Chavinier E; Warnet JM; Rat P Cornea; 2009 Oct; 28(9):1032-41. PubMed ID: 19724206 [TBL] [Abstract][Full Text] [Related]
20. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops. Ousler GW; Michaelson C; Christensen MT Cornea; 2007 Sep; 26(8):949-52. PubMed ID: 17721294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]